Seqens Seqens

X

Find the latest Drugs in Development and Pipeline Prospector News of Abbott Laboratories.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Abbott Laboratories
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
100 Abbott Park Road, Abbott Park, IL 60064 - (224) 667-6100
Telephone
Telephone
+91-22-3816 2000

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Under the agreemeent, Abbott will commercialize several biosimilar molecules in key emerging markets in Latin America, Southeast Asia, the Middle East and Africa, and mAbxience will develop, manufacture and supply the biosimilar molecules.


Lead Product(s): Undisclosed

Therapeutic Area: Oncology Product Name: Undisclosed

Highest Development Status: UndisclosedProduct Type: Large molecule

Recipient: Mabxience

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement September 20, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Under the agreement, Abbott has exclusive worldwide commercialization rights for the SurVeil (paclitaxel) drug-coated balloon (DCB) for which Surmodics received FDA approval.


Lead Product(s): Paclitaxel

Therapeutic Area: Cardiology/Vascular Diseases Product Name: SurVeil

Highest Development Status: ApprovedProduct Type: Small molecule

Recipient: Surmodics

Deal Size: $92.0 million Upfront Cash: $25.0 million

Deal Type: Agreement June 20, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

EleCare formulas are hypoallergenic and are used by infants and children who have severe food allergies or gastrointestinal (GI) disorders that require amino acid-based formulas.


Lead Product(s): Amino Acid-Based Therapeutic

Therapeutic Area: Nutrition and Weight Loss Product Name: Elecare

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable May 24, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

The novel, room-temperature-stable (RTS), single-dose formulation of Carbetocin will address prevailing challenges with existing protocols that require cold-chain storage and transportation.


Lead Product(s): Carbetocin Acetate

Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Product Name: Undisclosed

Highest Development Status: ApprovedProduct Type: Peptide

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable August 31, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Estradiol, also spelled oestradiol, is an estrogen steroid hormone and the major female sex hormone. It is involved in the regulation of the estrous and menstrual female reproductive cycles.


Lead Product(s): Estradiol,Dydrogesterone

Therapeutic Area: Musculoskeletal Product Name: Femoston

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 15, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

After termination of the agreement, AstraZeneca India will continue to independently market Dapagliflozin, the combinations of Dapagliflozin and Metformin as well as Dapagliflozin and Saxagliptin in India under the brand names Forxiga, Xigduo and Qtern respectively.


Lead Product(s): Dapagliflozin Propanediol Monohydrate,Metformin

Therapeutic Area: Endocrinology Product Name: Xigduo

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: AstraZeneca

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Termination May 28, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

This is the first Investigational Device Exemption (IDE) trial in the U.S. to evaluate a fully resorbable device to treat blocked arteries below the knees, or critical limb ischemia (CLI), in people battling advanced stages of peripheral artery disease (PAD).


Lead Product(s): Everolimus

Therapeutic Area: Cardiology/Vascular Diseases Product Name: ESPRIT BTK

Highest Development Status: UndisclosedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 03, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Approval marks the first once-a-day formulation for Ivabradine in India, which will help increase adherence to therapy for chronic heart failure and chronic stable angina.


Lead Product(s): Ivabradine Hydrochloride

Therapeutic Area: Cardiology/Vascular Diseases Product Name: Undisclosed

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 02, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY